文献
J-GLOBAL ID:201802289317780499
整理番号:18A2157589
結腸直腸癌における同時RASおよびBRAF変異を検出するためのLuminex XMAP技術を用いた新たに開発された多重キットの臨床的検証: RASKET-B研究の結果【JST・京大機械翻訳】
Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study
著者 (16件):
Taniguchi Hiroya
(Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya-shi Aichi-ken, 464-8681, Japan)
,
Taniguchi Hiroya
(Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken, 277-8577, Japan)
,
Okamoto Wataru
(Biobank translational research support section, Translational research management division, Clinical Research Support Office, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken, 277-8577, Japan)
,
Muro Kei
(Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya-shi Aichi-ken, 464-8681, Japan)
,
Akagi Kiwamu
(Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, 818 Komuro, Ina-machi Kitaadachi-gun, Saitama-ken, 362-0806, Japan)
,
Hara Hiroki
(Department of Gastroenterology, Saitama Cancer Center, 818 Komuro, Ina-machi Kitaadachi-gun, Saitama-ken, 362-0806, Japan)
,
Nishina Tomohiro
(Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-machi, Matsuyama-shi, Ehime-ken, 791-0280, Japan)
,
Kajiwara Takeshi
(Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemoto-machi, Matsuyama-shi, Ehime-ken, 791-0280, Japan)
,
Denda Tadamichi
(Division of Gastroenterology, Chiba Cancer Center Hospital, 666-2 Nitona-Cho, Chuo-ku, Chiba-ken, 260-8717, Japan)
,
Hironaka Shuichi
(Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu-shi, Oita-ken, 879-5593, Japan)
,
Kudo Toshihiro
(Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka-fu, 565-0871, Japan)
,
Satoh Taroh
(Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka-fu, 565-0871, Japan)
,
Yamanaka Takeharu
(Department of Biostatistics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa, 236-0004, Japan)
,
Abe Yukiko
(Medical and Biological Laboratories Co. Ltd., KDX Nagoya Sakae Building 10F 4-5-3 Sakae, Naka-ku Nagoya-shi, Aichi-ken 460-0008, Japan)
,
Fukushima Yoshiyuki
(Medical and Biological Laboratories Co. Ltd., KDX Nagoya Sakae Building 10F 4-5-3 Sakae, Naka-ku Nagoya-shi, Aichi-ken 460-0008, Japan)
,
Yoshino Takayuki
(Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi, Chiba-ken, 277-8577, Japan)
資料名:
Neoplasia
(Neoplasia)
巻:
20
号:
12
ページ:
1219-1226
発行年:
2018年
JST資料番号:
W3158A
ISSN:
1476-5586
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)